While most TRIOBP mutations implicated in deafness were found in patients with severe or profound hearing loss detected before speaking, compound heterozygous mutations have been reported in patients with moderate hearing loss or later onset severe hearing loss (Table 1). Here, TRIOBP is linked to deafness.